LEWICKI JOHN A. (Chief Scientific Officer) sold 17.0% of their position (16.15K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $69.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/16/2024ACC: 0000950170-24-106974
Officer· Chief Scientific Officer
Since Feb 2026
-16.15K
Net shares
Net seller
$69.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.15K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−5.21K
Price / share
$4.47
Trade value
$23.31K
% of position
5.5%
9/12/2024
94.78K→89.57K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−10.94K
Price / share
$4.22
Trade value
$46.17K
% of position
12.2%
9/13/2024
89.57K→78.63K
Total
Net shares
−16.15K
Net value
-$69.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −5.21K | $4.47 | $23.31K | 5.5% | 94.78K | 89.57K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −10.94K | $4.22 | $46.17K | 12.2% | 89.57K | 78.63K |
| Total | −16.15K | -$69.48K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares representing Ordinary Shares
IndirectShares owned14.20K
Total
14.20K indirect14.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares representing Ordinary Shares | 14.20K | Indirect |
| Total | 14.20K | 14.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported